Chinook Therapeutics, Inc.
KDNYDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001435049
Chinook Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 185 institutions reported holding it in 13F filings for Q2 2023, worth $2.24B in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Chinook Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 157
- +4 vs. Q4 2022
- Shares held
- 61.5M
- +2.78M (+4.7%) vs. Q4 2022
- Total value
- $1.42B
- −$98.0M (−6.4%) vs. Q4 2022
- New holders
- 20
- 57 more added
- Sold out
- 16
- 49 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KDNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 2 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 2 | $0 |
| Q2 2023 | 185 | $2.24B |
| Q1 2023 | 157 | $1.42B |
| Q4 2022 | 155 | $1.52B |
| Q3 2022 | 151 | $1.12B |
| Q2 2022 | 135 | $930.3M |
| Q1 2022 | 105 | $727.3M |
| Q4 2021 | 103 | $707.4M |
| Q3 2021 | 85 | $361.6M |
| Q2 2021 | 89 | $372.0M |
| Q1 2021 | 77 | $366.1M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Chinook Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Investments, LP | 154,265 | $3.57M | 0.01% | +15,637+11.3% | Added |
| JPMorgan Chase & Co | 157,964 | $3.66M | 0.00% | +5,979+3.9% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 170,211 | $3.94M | 0.02% | −65,605−27.8% | Reduced |
| Polar Capital Holdings Plc | 175,000 | $4.05M | 0.03% | +175,000 | New |
| Putnam Investments LLC | 180,343 | $4.17M | 0.01% | −3,000−1.6% | Reduced |
| Rafferty Asset Management, LLC | 181,074 | $4.19M | 0.03% | +7,063+4.1% | Added |
| Bank of New York Mellon Corp | 195,352 | $4.52M | 0.00% | −25,707−11.6% | Reduced |
| MPM Oncology Impact Management LP | 197,806 | $4.58M | 1.19% | +117,806+147.3% | Added |
| Two Sigma Advisers, LP | 214,880 | $4.97M | 0.01% | −22,100−9.3% | Reduced |
| Millennium Management LLC | 248,454 | $5.75M | 0.01% | −192,284−43.6% | Reduced |
| Morgan Stanley | 251,840 | $5.83M | 0.00% | −30,171−10.7% | Reduced |
| Artal Group S.A. | 258,687 | $5.99M | 0.36% | +258,687 | New |
| FMR LLC | 264,760 | $6.13M | 0.00% | −42,050−13.7% | Reduced |
| Ikarian Capital, LLC | 283,464 | $6.56M | 2.72% | 00.0% | Unchanged |
| Altium Capital Management LP | 305,000 | $7.06M | 4.22% | −80,000−20.8% | Reduced |
| Erste Asset Management GmbH | 307,769 | $7.12M | 0.14% | 00.0% | Unchanged |
| Bank of America Corp | 314,675 | $7.28M | 0.00% | +139,652+79.8% | Added |
| D. E. Shaw & Co., Inc. | 319,706 | $7.40M | 0.01% | −40,079−11.1% | Reduced |
| International Biotechnology Trust PLC | 319,989 | $7.41M | 2.07% | −20,400−6.0% | Reduced |
| Goldman Sachs Group Inc | 349,306 | $8.09M | 0.00% | +137,130+64.6% | Added |
| Ensign Peak Advisors, Inc | 361,838 | $8.38M | 0.02% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 378,127 | $8.75M | 0.00% | −5,585−1.5% | Reduced |
| Walleye Capital LLC | 394,100 | $9.12M | 0.18% | +262,725+200.0% | Added |
| EcoR1 Capital, LLC | 445,550 | $10.3M | 0.33% | −244,450−35.4% | Reduced |
| Baillie Gifford & Co | 486,595 | $11.3M | 0.01% | −3,113−0.6% | Reduced |
| Saturn V Capital Management LLC | 506,818 | $11.7M | 8.76% | +83,641+19.8% | Added |
| Rock Springs Capital Management LP | 507,512 | $11.7M | 0.28% | 00.0% | Unchanged |
| Northern Trust Corp | 533,104 | $12.3M | 0.00% | −708−0.1% | Reduced |
| Rubric Capital Management LP | 719,809 | $16.7M | 0.66% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 732,169 | $16.9M | 0.06% | −535,491−42.2% | Reduced |
| Nuveen Asset Management, LLC | 746,172 | $17.3M | 0.01% | −170,593−18.6% | Reduced |
| Driehaus Capital Management LLC | 755,336 | $17.5M | 0.25% | −17,364−2.2% | Reduced |
| Laurion Capital Management LP | 829,750 | $19.2M | 0.87% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 926,155 | $19.7M | 0.14% | 00.0% | Unchanged |
| Vivo Capital, LLC | 872,151 | $20.2M | 1.51% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 948,551 | $22.0M | 0.00% | +34,325+3.8% | Added |
| Nicholas Investment Partners, LP | 972,191 | $22.5M | 1.71% | +329,471+51.3% | Added |
| Affinity Asset Advisors, LLC | 976,021 | $22.6M | 8.68% | +157,986+19.3% | Added |
| Victory Capital Management Inc | 991,014 | $22.9M | 0.03% | −172,231−14.8% | Reduced |
| Sofinnova Investments, Inc. | 1,002,348 | $23.2M | 1.57% | +195,889+24.3% | Added |
| Pictet Asset Management SA | 1,174,756 | $27.2M | 0.03% | +8,592+0.7% | Added |
| Federated Hermes, Inc. | 1,252,388 | $29.0M | 0.07% | +363,934+41.0% | Added |
| Dimensional Fund Advisors LP | 1,284,521 | $29.7M | 0.01% | +46,441+3.8% | Added |
| Franklin Resources Inc | 1,312,158 | $30.4M | 0.02% | +1,312,158 | New |
| Assenagon Asset Management S.A. | 1,371,469 | $31.7M | 0.13% | +483,220+54.4% | Added |
| Eventide Asset Management, LLC | 1,439,564 | $33.3M | 0.61% | +1,070,753+290.3% | Added |
| Baker Bros. Advisors LP | 1,455,202 | $33.7M | 0.18% | −1,078,900−42.6% | Reduced |
| Suvretta Capital Management, LLC | 1,568,797 | $36.3M | 1.75% | +123,967+8.6% | Added |
| Adage Capital Partners GP, L.L.C. | 1,704,000 | $39.4M | 0.09% | +883,822+107.8% | Added |
| OrbiMed Advisors LLC | 2,029,300 | $47.0M | 0.93% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 2,551,703 | $59.1M | 8.52% | 00.0% | Unchanged |
| State Street Corp | 2,688,048 | $62.2M | 0.00% | +29,092+1.1% | Added |
| Vanguard Group Inc | 2,847,835 | $65.9M | 0.00% | +55,261+2.0% | Added |
| Deep Track Capital, LP | 3,000,000 | $69.5M | 2.95% | 00.0% | Unchanged |
| BlackRock Inc. | 3,942,539 | $91.3M | 0.00% | −12,202−0.3% | Reduced |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $100.6M | 7.28% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 5,161,888 | $119.5M | 24.70% | 00.0% | Unchanged |
| Woodline Partners LP | 0 | $0 | 0.00% | −142,563−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −128,955−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −90,140−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −90,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −78,000−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −66,787−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −45,868−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −26,992−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −25,211−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −18,931−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −13,555−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,134−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,502−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −42,852−100.0% | Sold out |
| HealthCor Management, L.P. | – | – | – | – | Not filed |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |